A correspondence in The Lancet argues that the NordICC trial's modest reductions in colorectal cancer incidence and mortality must be understood in the context of widespread colonoscopy use during the study period.
NordICC Colonoscopy Trial Results Fall Short of Expectations, Researchers Say
A correspondence in The Lancet argues that the NordICC trial's modest reductions in colorectal cancer incidence and mortality must be understood in the context of widespread colonoscopy use during the study period.
![[Correspondence] Colonoscopy screening and colorectal cancer outcomes: the NordICC trial](https://nbg1.your-objectstorage.com/ckln/image-assets/58078ceddc5ac651c5c77c82cd2ebbbb1c911b79c5cfb2775842b0a224633c20.jpg)
Yazan.shawahneh · Public domain · rights
Monitoring item. The full text is not distributed. Extract and source below.